This site is intended for health professionals only

At the heart of general practice since 1960

Read the latest issue online

Gold, incentives and meh

Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Your comments will be sent to our moderator for review.

Report comment to moderator

Required fields.


Consider stopping treatment with 'limited benefit' in multimorbidity, advises NICE


I think the main value of these guidelines is a back up for those occasions when we already want to reduce excess treatment-I am often held back from stopping polypharmacy because there is always the concern-if I stop this antiplatelt/antihypertensive or whatever on grounds of low benefit, a patient could potentially then have a hemiplegic stroke/arrhythmic collapse which might have happened anyway but there will always be a possibility that it was causative.Defensive medicine thinking competing with patient centred care maybe, but Nice not substitute for clinical judgment.

Posted date

21 Sep 2016

Posted time